摘要
目的通过CAG联合诱导方案治疗难治性复发性急性髓系白血病患者,分析CAG联合诱导方案在临床的应用效果。方法对11例复发急性髓系白血病CAG预激方案诱导治疗及临床转归进行分析研究。结果11例复发急性髓系白血病,完全缓解6例占54.5%,部分缓解3例占27.3%,未缓解2例占18.2%。结论CAG方案对难治性复发性AML患者有积极的治疗作用,治疗过程中感染、出血等并发症少,无严重毒副作用和治疗相关死亡,是治疗难治性AML的有效治疗措施。
Objective Through the CAG union induction plan treatment difficult recurrence acute marrow is the leukemia patient,analyzes the CAG union induction plan in the clinical application effect.Methods Is leukemia CAG stirs up the plan induction treatment and the clinical extension in advance to 11 example recrudescence acute marrow turns over to conduct the analytical study.Results 11 example recrudescence acute marrow is a leukemia,alleviates 6 examples to account for 54.5%completely,the part alleviates 3 examples to account for 27.3%,has not alleviated 2 examples to account for 18.2%.Conclusion The CAG plan has the positive therapeutic action to the difficult recurrence AML patient,in the course of treatment infects,complications and so on hemorrhage to be few,not serious poisonous side effect and the treatment related death,are treat difficult AML the effective remedial measure.
出处
《中国实用医药》
2010年第7期28-30,共3页
China Practical Medicine
关键词
复发急性髓系白血病
CAG联合诱导方案
临床转归
Recurs the acute marrow is the leukemia
CAG union induction plan
The clinical extension turns over to
